Which type of vaccine is the hepatitis B vaccine?

The hepatitis B vaccine is a non-live recombinant vaccine that uses a surface protein to prepare immune defences. It does not contain the complete virus, so vaccination cannot cause hepatitis B.

Recombinant production makes a selected hepatitis B surface protein without growing a complete infectious virus in the person receiving the vaccine. The immune system learns to recognise that protein and can respond more quickly if it later encounters hepatitis B. This is prevention, not treatment for someone who already has the infection.

The vaccine type is separate from the way it is administered: a healthcare professional gives it by injection into a muscle. Local soreness and short-lived tiredness can follow. They do not tell you whether a person has hepatitis B; symptoms such as dark urine or fatigue need their own assessment.

Check your vaccination history with a healthcare professional and ask which schedule fits your age, work, travel, medical history, or exposure risk. Mention severe allergies, pregnancy, immune conditions, and medicines that suppress immunity before the dose. Keep each appointment record because protection depends on following the advised series.

For broader scheduling information, visit [Hepatitis B Vaccination](/treatments/preventive-care-and-vaccination/hepatitis-b-vaccination/).

Seek emergency care for breathing difficulty, swelling of the face or throat, widespread hives, fainting, or severe dizziness after the injection. Speak with a clinician about a reaction that is worsening or persistent, or about significant fever or illness. If you may have been exposed to hepatitis B, prompt advice matters even if you feel well; a liver function test may be part of an assessment.

Ask whether the product offered is recombinant, how many appointments your schedule requires, and what to do if one is delayed. Ask whether blood testing is appropriate after exposure or for ongoing symptoms, and how results would affect follow-up.